ライフサイエンスコーパス: anti-hypertensive

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ANP exhibits several potent anti-hypertensive actions in the kidney, adrenal gland a

2 or enzastaurin, and the clinically available anti-hypertensive agent hydralazine, both normalize aort

3 Since it was discovered that the anti-hypertensive agent ifenprodil has neuroprotective a

4 ars posttransplantation and increased use of anti-hypertensive agents, low-dose CsA was not associate

5 channel blockers (CCB) are widely prescribed anti-hypertensive agents.

6 We show that the diuretic, anti-hypertensive, AMPA receptor modulator cyclothiazide

7 evalence have corresponded with increases in anti-hypertensive and lipid-modifying drugs, respectivel

8 ted glomerular filtration rate, medications (anti-hypertensive and statin), LV mass index, and interi

9 se was estimated for lipid-modifying agents, anti-hypertensives, and anti-hyperglycemic medications.

10 therapeutics, anti-tumor drugs, antibiotics, anti-hypertensives, and anti-inflammatories.

11 therapeutics, anti-tumor drugs, antibiotics, anti-hypertensives, and anti-inflammatories.

12 chidonic acid (AA) metabolism and tend to be anti-hypertensive, anti-inflammatory and protective agai

13 nal revascularization as an aid in improving anti-hypertensive control, preserving renal function, an

14 designed to test the effectiveness of three anti-hypertensive drug regimens and two levels of BP con

15 The three anti-hypertensive drug regimens include an angiotensin c

16 ne, a well tolerated, safe, centrally acting anti-hypertensive drug, could induce autophagy in cell c

17 st olmesartan (Benicar(TM)), a highly potent anti-hypertensive drug.

18 ave been widely used in clinical settings as anti-hypertensive drugs and share a similar chemical sca

19 Although several anti-hypertensive drugs have been developed as AT(1)R bl

20 range of organic anions including vitamins, anti-hypertensive drugs, anti-tumor drugs, and anti-infl

21 A (CsA) and also certain anti-epileptic and anti-hypertensive drugs.

22 common and distinct binding modes for these anti-hypertensive drugs.

23 bolism (anti-cholesterol), anti-diabetic and anti-hypertensive effects among others.

24 nzyme (ACE) inhibitor enalapril, but not the anti-hypertensive hydralazine, decreased pulmonary neutr

25 imated glomerular filtration rate, fat mass, anti-hypertensive medication and fasting glucose, (1) lo

26 survival, routine achievement of steroid and anti-hypertensive medication withdrawal, gratifying incr

27 rity of hypertension (need for more than one anti-hypertensive medication) was also significantly low

28 populations will respond to certain types of anti-hypertensive medication.

29 t of hypertension and use of renoprotective, anti-hypertensive medication.

30 ised blood pressure and less likely to be on anti-hypertensive medication; they are 45% more likely t

31 sfully transplanted patients were not taking anti-hypertensive medications.

32 The prevalence of anti-hypertensive pharmacologic therapy was 4.2% (95% CI

33 Anti-hypertensive requirement (32% TAC vs. 32% CsA) and

34 A maximal anti-hypertensive response of 33 +/- 5 mmHg was observed

35 effects of three medications used as initial anti-hypertensive therapy (ramipril, metoprolol, and aml

36 information and context on the intensity of anti-hypertensive therapy in conjunction with the releas

37 ety and efficacy of differing intensities of anti-hypertensive therapy in mild to moderate CKD, where

38 nsive kidney disease who receive recommended anti-hypertensive therapy.

39 um (CAC) can further guide the allocation of anti-hypertensive treatment intensity.

40 years posttransplantation and required more anti-hypertensive treatment throughout the study period.

41 including from maternal smoking and maternal anti-hypertensive treatment.

42 All anti-hypertensive treatments have shown improvement in r

43 The anti-hypertensive, vasodilatory, anti-fibrotic, and anti

44 azide diuretics (TD) are commonly prescribed anti-hypertensives worldwide.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。